TechNavio's analysts forecast the Global Intravenous Solutions market to grow at a CAGR of 12.08 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing cases of out-patient intravenous therapies. The Global Intravenous Solutions market has also been witnessing an increasing focus on product launches. However, the adverse effects of ketorolac trometamol could pose a challenge to the growth of this market.
TechNavio's report, the Global Intravenous Solutions Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intravenous Solutions market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include B. Braun Melsungen AG, Baxter International Inc., Hospira Inc., and Pfizer Inc.
Other vendors mentioned in the report: Fresenius Kabi AG, Liqvor Pharmaceuticals CJSC, Watson Pharmaceuticals Inc., Claris Lifesciences Ltd., Galenica Ltd., Grifols S.A., Sichuan Kelun Pharmaceutical Co. Ltd., Marck Biosciences Ltd., Otsuka Pharmaceutical Co. Ltd., Sino-Swed Pharmaceutical Corp. Ltd., and Terumo Medical Corp.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
For more information please visit link:
You can also request for sample page of above mention reports on: email@example.com